Providing you the best range of medicine drop shippers, 0.5 mg dutas dutasteride tablets and takfa capsules 1 mg with effective & timely delivery.
₹ 230 / Piece Get Latest Price
| Service Type | Medicine Dropship |
| Product Range | Branded Medicines, Allopathic, Surgical Items, Veterinary, Cosmetics, Generic Medicines, Nutraceutical |
| Coverage Area | Export Only |
| MOQ Per Order | No MOQ |
| Packing Type | Plain Packing |
| Dispatch Time | 2-3 Working Days |
| Cold Chain Support | Yes |
| Regulatory Support | Export Docs |
₹ 203 / Strip Get Latest Price
| Strength | 0.5 mg |
| Combination | Dutasteride |
| Pack Size | 30 capsules |
| Brand Type | Branded |
| Indication | Hair Loss |
| Prescription | Prescription |
| Dosage Form | Softgel Capsule |
| Packaging Type | Strip Pack |
Minimum order quantity: 1 Strip
Dutas 0.5 mg Dutasteride Tablets are a prescription medication widely used for the treatment of benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate gland commonly seen in middle-aged and elderly men. The active ingredient, dutasteride 0.5 mg, belongs to the class of drugs known as 5-alpha reductase inhibitors, which work by addressing the hormonal imbalance responsible for prostate growth.
Dutasteride acts by inhibiting both type I and type II 5-alpha reductase enzymes. These enzymes convert testosterone into dihydrotestosterone (DHT), a potent androgen that stimulates prostate enlargement. By significantly reducing DHT levels in the body, Dutas 0.5 mg helps shrink the prostate over time, thereby relieving urinary obstruction and improving overall urinary function. This dual-enzyme action makes dutasteride highly effective in reducing prostate volume and preventing disease progression.
Dutas 0.5 mg tablets are prescribed to manage urinary symptoms associated with BPH, including frequent urination, difficulty in starting urination, weak urine stream, dribbling, and increased nighttime urination (nocturia). With consistent use, the medication can lower the risk of acute urinary retention and decrease the likelihood of requiring surgical treatment for prostate enlargement. Patients should note that symptomatic improvement may take several weeks to months, as hormonal changes occur gradually.
The usual recommended dosage of Dutas is one 0.5 mg tablet taken once daily, with or without food. The tablet should be swallowed whole and not crushed or chewed, as direct contact with the drug may cause skin absorption. Treatment should be continued regularly as prescribed by a healthcare professional to maintain its therapeutic benefits.
In some cases, dutasteride is also used off-label for the treatment of androgenetic alopecia (male pattern hair loss). By lowering DHT levels in the scalp, it may slow hair thinning and promote hair retention. However, this use should only be undertaken with medical supervision due to potential hormonal side effects.
Like all medicines, Dutas 0.5 mg Dutasteride Tablets may cause side effects in some individuals. Common side effects include reduced sexual desire, erectile dysfunction, ejaculation disorders, and breast tenderness or enlargement. These effects are usually mild and reversible upon discontinuation. Rarely, allergic reactions or mood changes may occur, and any unusual symptoms should be reported to a healthcare provider.
Dutas 0.5 mg should not be used by women or children. Pregnant women, or those planning pregnancy, must avoid handling broken tablets due to the risk of absorption through the skin, which may harm a developing male fetus.
In conclusion, Dutas 0.5 mg Dutasteride Tablets provide effective long-term management of benign prostatic hyperplasia by targeting the hormonal cause of prostate enlargement. When used as directed under medical supervision, the medication helps improve urinary symptoms, reduces complications, and enhances quality of life.
₹ 434 / Strip Get Latest Price
| Strength | 1 mg |
| Brand | Takfa |
| Release Form | Immediate Release |
| Packaging Size | 10 capsules |
| Packaging Type | Blister |
| Indication | Lung Transplant, Heart Transplant, Liver Transplant, Kidney Transplant |
| Manufacturer | Intas Pharma |
| Prescription Type | Prescription |
| Shelf Life | 24 months |
Takfa 1 mg Tacrolimus Tablet is an immunosuppressive medication widely used to prevent organ rejection in patients who have undergone organ transplantation, such as kidney, liver, or heart transplants. It contains tacrolimus as its active ingredient, which belongs to a class of medicines known as calcineurin inhibitors. Takfa helps suppress the body’s immune response, reducing the risk of the immune system attacking the transplanted organ.
Tacrolimus works by inhibiting the activity of calcineurin, an enzyme involved in the activation of T-lymphocytes. T-cells play a key role in the immune response and are responsible for recognizing and attacking foreign tissues, including transplanted organs. By suppressing T-cell activation, Takfa 1 mg Tablet helps maintain immune balance and improves the long-term success of organ transplantation.
Takfa 1 mg Tacrolimus Tablet is usually prescribed as part of a combination immunosuppressive regimen, often alongside corticosteroids or other immunosuppressants. The dosage is carefully individualized based on factors such as the type of transplant, patient’s body weight, blood tacrolimus levels, kidney function, and overall clinical condition. The tablet is typically taken twice daily, at the same times each day, with or without food, as directed by a transplant specialist.
In addition to transplant medicine, tacrolimus may also be used in certain autoimmune disorders, such as severe rheumatoid arthritis, lupus nephritis, or inflammatory bowel disease, under specialist supervision. However, such uses depend on the patient’s condition and medical judgment.
Like all immunosuppressive medicines, Takfa 1 mg Tablet may cause side effects. Common side effects include tremors, headache, nausea, diarrhea, increased blood pressure, kidney function changes, and elevated blood sugar levels. Because tacrolimus suppresses the immune system, patients may also be at an increased risk of infections. Regular monitoring through blood tests is essential to ensure safe and effective therapy.
Long-term use of tacrolimus may be associated with kidney toxicity, electrolyte imbalances, increased cholesterol levels, and neurological symptoms such as tingling or confusion. Doctors closely monitor tacrolimus blood levels to maintain them within a therapeutic range and minimize adverse effects.
Certain precautions should be taken while using Takfa 1 mg Tacrolimus Tablet. Patients should avoid grapefruit and grapefruit juice, as they can increase tacrolimus levels in the blood and raise the risk of toxicity. It is important to inform the doctor about all other medications, supplements, or herbal products being taken, as tacrolimus has several potential drug interactions.
Takfa 1 mg Tablet should be used with caution in patients with kidney or liver disease, diabetes, or high blood pressure. Pregnant and breastfeeding women should consult their healthcare provider before using this medication, as the benefits and risks must be carefully evaluated.
SUNRISE GLOBAL (Owner)
Sunrise Global Exim
1st Floor, Shop No.F35, Ginger Mall, Main Road, Old Jaripatka, Ginger Square
Nagpur - 440014, Maharashtra, India